Laporan Laba Rugi (TTM)
Laporan Laba Rugi Sunshine Biopharma, Inc. - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 9 | 15 | 20 | 24 | 27 | 30 | 33 | 35 | 36 | 36 |
| Change (%) | 32.36 | 40.55 | 37.59 | 24.06 | 33.33 | 36.15 | 31.33 | 20.18 | 785.27 | 109.80 | 59.35 | 40.10 | 18.38 | 10.99 | 13.99 | 8.13 | 5.81 | 3.90 | 0.30 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 6 | 9 | 13 | 16 | 18 | 21 | 23 | 24 | 25 | 24 |
| Change (%) | 32.08 | 56.63 | 32.99 | 24.45 | 75.86 | 35.07 | 35.29 | 21.49 | 912.63 | 113.48 | 62.48 | 42.46 | 20.35 | 13.46 | 18.68 | 7.55 | 6.09 | 4.07 | -3.81 | |
| % of Revenue | 36.27 | 36.20 | 40.34 | 38.99 | 39.11 | 51.58 | 51.17 | 52.72 | 53.29 | 60.96 | 62.03 | 63.25 | 64.32 | 65.39 | 66.85 | 69.59 | 69.22 | 69.40 | 69.52 | 66.67 |
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 5 | 7 | 8 | 9 | 9 | 10 | 11 | 11 | 12 |
| Change (%) | 32.51 | 31.43 | 40.71 | 23.81 | 6.02 | 37.31 | 27.17 | 18.72 | 639.96 | 104.05 | 54.22 | 36.02 | 14.83 | 6.31 | 4.55 | 9.45 | 5.18 | 3.52 | 9.66 | |
| % of Revenue | 63.73 | 63.80 | 59.66 | 61.01 | 60.89 | 48.42 | 48.83 | 47.28 | 46.71 | 39.04 | 37.97 | 36.75 | 35.68 | 34.61 | 33.15 | 30.41 | 30.78 | 30.60 | 30.48 | 33.33 |
| SG&A | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 9 | 12 | 13 | 14 | 11 | 11 | 12 | 13 | 15 | 15 | 16 |
| Change (%) | 20.24 | 178.99 | 5.49 | 12.71 | -7.28 | -11.03 | 29.83 | 51.98 | 189.38 | 23.26 | 15.24 | 7.13 | -24.91 | 2.20 | 4.86 | 11.58 | 15.35 | 1.82 | 6.53 | |
| % of Revenue | 935.13 | 849.52 | 1,686.28 | 1,292.87 | 1,174.58 | 816.80 | 533.73 | 527.65 | 667.25 | 218.11 | 128.14 | 92.67 | 70.86 | 44.95 | 41.39 | 38.07 | 39.29 | 42.83 | 41.97 | 44.58 |
| R&D | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
| Change (%) | ∞ | 9,651.97 | 113.79 | 61.75 | 15.35 | 28.99 | -16.82 | 19.42 | -5.74 | 8.78 | 36.53 | -10.32 | 71.64 | -11.36 | 4.11 | -6.52 | -41.67 | -0.72 | -25.89 | |
| % of Revenue | 0.00 | 2.42 | 167.90 | 260.89 | 340.14 | 294.28 | 278.79 | 176.59 | 175.46 | 18.68 | 9.69 | 8.30 | 5.31 | 7.70 | 6.15 | 5.62 | 4.86 | 2.68 | 2.56 | 1.89 |
| OpEx | 1 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 13 | 18 | 24 | 29 | 29 | 31 | 35 | 38 | 41 | 42 | 42 |
| Change (%) | 20.48 | 195.42 | 15.55 | 20.89 | -0.25 | 1.14 | 14.99 | 42.02 | 195.39 | 41.30 | 31.34 | 19.97 | -0.38 | 7.51 | 12.91 | 8.17 | 7.29 | 3.21 | -0.52 | |
| % of Revenue | 997.35 | 907.83 | 1,908.20 | 1,602.48 | 1,561.48 | 1,168.24 | 867.77 | 759.83 | 897.91 | 299.60 | 201.78 | 166.32 | 142.43 | 119.86 | 116.11 | 115.00 | 115.05 | 116.67 | 115.89 | 114.95 |
| Operating Income | -0 | -1 | -2 | -2 | -3 | -2 | -2 | -3 | -4 | -9 | -9 | -10 | -9 | -5 | -4 | -5 | -5 | -6 | -6 | -5 |
| Change (%) | 19.15 | 214.60 | 14.33 | 20.67 | -2.54 | -2.14 | 12.87 | 45.33 | 121.46 | 6.98 | 3.82 | -10.37 | -44.58 | -10.00 | 6.20 | 8.48 | 17.14 | -0.94 | -5.64 | |
| % of Revenue | -897.35 | -807.83 | -1,808.20 | -1,502.48 | -1,461.48 | -1,068.24 | -767.77 | -659.83 | -797.91 | -199.60 | -101.78 | -66.32 | -42.43 | -19.86 | -16.11 | -15.00 | -15.05 | -16.67 | -15.89 | -14.95 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |
| Change (%) | 95.27 | 19.84 | 85.08 | 6.64 | -17.30 | -11.21 | -67.00 | -48.62 | -20.37 | 71.58 | -49.29 | 289.99 | 2.66 | 5.90 | -10.73 | -76.62 | -71.10 | |||
| % of Revenue | -159.56 | -235.41 | -200.73 | -270.01 | -232.09 | -143.95 | -93.88 | -23.59 | -10.08 | -0.91 | -0.74 | -0.24 | -0.66 | -0.57 | -0.54 | -0.43 | -0.09 | -0.03 | -0.02 | |
| Net Income | -2 | -3 | -9 | -11 | -14 | -12 | -7 | -5 | -3 | -27 | -27 | -28 | -27 | -5 | -4 | -4 | -4 | -5 | -5 | -6 |
| Change (%) | 32.77 | 218.77 | 22.22 | 30.80 | -12.34 | -39.79 | -31.25 | -50.17 | 942.66 | 1.74 | 1.33 | -2.92 | -83.17 | -9.29 | -9.98 | 14.85 | 21.49 | -2.03 | 25.38 | |
| % of Revenue | -3,886.56 | -3,898.74 | -8,842.59 | -7,854.43 | -8,281.16 | -5,444.41 | -2,407.47 | -1,260.23 | -522.53 | -615.44 | -298.46 | -189.80 | -131.52 | -18.70 | -15.29 | -12.07 | -12.82 | -14.72 | -13.88 | -17.35 |
Source: Capital IQ
